A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs" is generating significant coverage in the Business category, with 14 articles from 13 distinct sources tracked by PULSE so far.
Outlets currently covering the story include WKRG, University of Cincinnati, Mirage News and Baltimore Sun. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 74d ago.
Quick answers
Why is "A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs" trending?
Because 13 independent news sources published 14 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (14)
- Medical Moment: What to know about the newly approved drug to treat pancreatic cancer WKRG · 78d ago
- Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug University of Cincinnati · 78d ago
- Cancer Center Aids Key Trials for New Pancreatic Drug Mirage News · 78d ago
- Cancer breakthroughs give something to cheer about Baltimore Sun · 78d ago
- St. Johnsbury woman finds hope in new pancreatic cancer drug after losing husband WCAX · 78d ago
- 'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval MedPage Today · 78d ago
- New pancreatic cancer pill priced at $480,000 per year KTLA · 78d ago
- FDA approves new drug Rasonque to treat advanced pancreatic cancer France 24 · 79d ago
- 6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You Cure Today · 79d ago
- Baldwin County widower shares how his late wife helped advance cancer research WKRG · 79d ago
- FDA Approves Rasonque as Pancreatic Cancer Treatment MyChesCo · 79d ago
- St. Charles provides early access to new pancreatic cancer drug bendbulletin.com · 79d ago
- We’re reading about drug pricing deals, a new cancer therapy approval, and more STAT · 79d ago
- A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs The New York Times · 79d ago
Topics
Related trends
‘Star Wars: A New Hope’ Set For IMAX 70mm Re-Release
Lucasfilm plans to unveil its future Star Wars movie slate at Star Wars Celebration in London next April, ending a theatrical drought since 2019's The Rise of Skywalker.
‘Y&R’s New Head Writers Promise ‘Sexy’ Next Chapter and Cast Surprises
New head writers for 'The Young and the Restless' preview explosive shifts, a sexy next chapter, and major cast surprises.
Treasury Rally Gets New Boost as Election Hammers the AI Trade
Treasury markets rally as a U.S. stock selloff and midterm election results impact investor focus.
New treatment may cure common hormonal cause of high blood pressure
A small study found that extended treatment with the aldosterone synthase inhibitor baxdrostat led to sustained blood pressure reduction for up to two years after patients stopped taking the drug.
The New York Times Doesn’t Understand AI’s Role in Suppressing Wages
Five business outlets report a wave of debate over how AI agents reshape management pay, headcount models and performance metrics across industries.
No clear winner after tight New Zealand general election
New Zealand faces weeks of political uncertainty after a knife-edge election left the National-led coalition with a projected one-seat majority and nearly 400,000 special votes still to be counted.